1. Industry stalwart Ranjit Shahani passing away
2. Global drug maker balancing needs amid patent challenge on Gleevec.
By Trend News Line 2024-03-09 06:14:43.
Ranjit Shahani, Industry Stalwart and Former Novartis India Head, Passes Away
Ranjit Shahani, a well-respected figure in the pharmaceutical industry, has sadly passed away. Shahani was known for his remarkable grace and friendly demeanor towards everyone he encountered. He played a significant role during the challenging times of patent disputes over the cancer drug Gleevec, where he worked tirelessly to strike a balance between the interests of a global pharmaceutical company and the needs of Indian patients.
Shahani’s contributions to the healthcare sector were widely recognized, and his legacy will continue to inspire future generations of industry professionals. His dedication to improving access to life-saving medications for patients in India and beyond left a lasting impact on the industry.
At the time of this reporting, the cause of Ranjit Shahani’s death remains unknown. His sudden passing has left many in the industry in shock and mourning. Colleagues and friends have expressed their condolences and shared fond memories of working with Shahani over the years.
Shahani’s leadership at Novartis India was instrumental in shaping the company’s presence in the region and fostering collaborations with healthcare providers and regulatory authorities. He was a visionary leader who championed innovation and patient-centric approaches to healthcare delivery.
Throughout his career, Shahani was known for his integrity, professionalism, and commitment to ethical business practices. He was a role model for many in the industry and set high standards for corporate governance and social responsibility.
As we reflect on the life and legacy of Ranjit Shahani, we remember a man who dedicated his career to making a positive impact on the world of healthcare. His passion for improving access to quality healthcare for all will be remembered and cherished by those who had the privilege of knowing him.
.
Source : VikasReports
Very sad to hear about the passing away of Ranjit Shahani, an industry stalwart who had a remarkable grace & was friendly to everyone. Amid the bitter years of patent challenge on Gleevec, he worked hard to balance the needs of a global drug maker and Indian patients. Om Shanti.
— Vikas Dandekar (@VikasReports) March 9, 2024
– Industry stalwart passing away Ranjit Shahani
– Gleevec patent challenge industry stalwart Ranjit Shahani.